This table contains 2394 series, with data for years 1991 - 1991 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Population group (19 items: Entire cohort; Income adequacy quintile 1 (lowest);Income adequacy quintile 2;Income adequacy quintile 3 ...), Age (14 items: At 25 years; At 30 years; At 40 years; At 35 years ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: Life expectancy; High 95% confidence interval; life expectancy; Low 95% confidence interval; life expectancy ...).

VITAL SIGNS INDICATOR Life Expectancy (EQ6)

FULL MEASURE NAME Life Expectancy

LAST UPDATED April 2017

DESCRIPTION Life expectancy refers to the average number of years a newborn is expected to live if mortality patterns remain the same. The measure reflects the mortality rate across a population for a point in time.

DATA SOURCE State of California, Department of Health: Death Records (1990-2013) No link

California Department of Finance: Population Estimates Annual Intercensal Population Estimates (1990-2010) Table P-2: County Population by Age (2010-2013) http://www.dof.ca.gov/Forecasting/Demographics/Estimates/

U.S. Census Bureau: Decennial Census ZCTA Population (2000-2010) http://factfinder.census.gov

U.S. Census Bureau: American Community Survey 5-Year Population Estimates (2013) http://factfinder.census.gov

CONTACT INFORMATION vitalsigns.info@mtc.ca.gov

METHODOLOGY NOTES (across all datasets for this indicator) Life expectancy is commonly used as a measure of the health of a population. Life expectancy does not reflect how long any given individual is expected to live; rather, it is an artificial measure that captures an aspect of the mortality rates across a population that can be compared across time and populations. More information about the determinants of life expectancy that may lead to differences in life expectancy between neighborhoods can be found in the Bay Area Regional Health Inequities Initiative (BARHII) Health Inequities in the Bay Area report at http://www.barhii.org/wp-content/uploads/2015/09/barhii_hiba.pdf. Vital Signs measures life expectancy at birth (as opposed to cohort life expectancy). A statistical model was used to estimate life expectancy for Bay Area counties and ZIP Codes based on current life tables which require both age and mortality data. A life table is a table which shows, for each age, the survivorship of a people from a certain population.

Current life tables were created using death records and population estimates by age. The California Department of Public Health provided death records based on the California death certificate information. Records include age at death and residential ZIP Code. Single-year age population estimates at the regional- and county-level comes from the California Department of Finance population estimates and projections for ages 0-100+. Population estimates for ages 100 and over are aggregated to a single age interval. Using this data, death rates in a population within age groups for a given year are computed to form unabridged life tables (as opposed to abridged life tables). To calculate life expectancy, the probability of dying between the jth and (j+1)st birthday is assumed uniform after age 1. Special consideration is taken to account for infant mortality.

For the ZIP Code-level life expectancy calculation, it is assumed that postal ZIP Codes share the same boundaries as ZIP Code Census Tabulation Areas (ZCTAs). More information on the relationship between ZIP Codes and ZCTAs can be found at http://www.census.gov/geo/reference/zctas.html. ZIP Code-level data uses three years of mortality data to make robust estimates due to small sample size. Year 2013 ZIP Code life expectancy estimates reflects death records from 2011 through 2013. 2013 is the last year with available mortality data. Death records for ZIP Codes with zero population (like those associated with P.O. Boxes) were assigned to the nearest ZIP Code with population. ZIP Code population for 2000 estimates comes from the Decennial Census. ZIP Code population for 2013 estimates are from the American Community Survey (5-Year Average). ACS estimates are adjusted using Decennial Census data for more accurate population estimates. An adjustment factor was calculated using the ratio between the 2010 Decennial Census population estimates and the 2012 ACS 5-Year (with middle year 2010) population estimates. This adjustment factor is particularly important for ZCTAs with high homeless population (not living in group quarters) where the ACS may underestimate the ZCTA population and therefore underestimate the life expectancy. The ACS provides ZIP Code population by age in five-year age intervals. Single-year age population estimates were calculated by distributing population within an age interval to single-year ages using the county distribution. Counties were assigned to ZIP Codes based on majority land-area.

ZIP Codes in the Bay Area vary in population from over 10,000 residents to less than 20 residents. Traditional life expectancy estimation (like the one used for the regional- and county-level Vital Signs estimates) cannot be used because they are highly inaccurate for small populations and may result in over/underestimation of life expectancy. To avoid inaccurate estimates, ZIP Codes with populations of less than 5,000 were aggregated with neighboring ZIP Codes until the merged areas had a population of more than 5,000. ZIP Code 94103, representing Treasure Island, was dropped from the dataset due to its small population and having no bordering ZIP Codes. In this way, the original 305 Bay Area ZIP Codes were reduced to 217 ZIP Code areas for 2013 estimates. Next, a form of Bayesian random-effects analysis was used which established a prior distribution of the probability of death at each age using the regional distribution. This prior is used to shore up the life expectancy calculations where data were sparse.

Life expectancy at birth and at age 65, by sex, on a three-year average basis.

This dataset contains healthy life expectancy and disability-free life expectancy by gender, from birth and age 65. Health life expectancy is defined as the average number of years a person aged 'x' would live in good/fairly good health if he or she experiences the particular area's age-specific mortality and health rates throughout their life. Disability-free life expectancy is defined as the average number of years a person aged 'x' would live disability-free (no limiting long-term illness) if he or she experienced the particular area's age-specific mortality and health rates throughout their life. The estimates are calculated by combining age and sex specific mortality rates, with age and sex specific rates on general health and limiting long-term illness. For more information see the ONS website: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies

This dataset presents the footprint of the average number of years a person is expected to live at birth by sex, assuming that the current age-specific death rates are experienced throughout their life. The data spans the years of 2011-2016 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS). The data is based on the Australian Institute of Health and Welfare (AIHW) analysis of life expectancy estimates as provided by the Australian Bureau of Statistics (ABS). Life expectancies at birth were calculated with reference to state/territory and Australian life tables (where appropriate) for a three year period. The disaggregation used for reporting life expectancy at birth is PHN area. These values are provided by the ABS. For further information about this dataset, visit the data source: Australian Institute of Health and Welfare - Life Expectancy and Potentially Avoidable Deaths 2014-2016 Data Tables. Please note: AURIN has spatially enabled the original data using the Department of Health - PHN Areas. Life expectancy for 2014-2016 are based on the average number of deaths over three years, 2014-2016, and the estimated resident population (ERP) as at 30 Jun 2015.

Life expectancy is the number of years a person would be expected to live, starting from birth (for life expectancy at birth) or at age 65 (for life expectancy at age 65), on the basis of the mortality statistics for a given observation period. Life expectancy is a widely used indicator of the health of a population. Life expectancy measures quantity rather than quality of life.

How much time do people spend on social media? As of 2025, the average daily social media usage of internet users worldwide amounted to 141 minutes per day, down from 143 minutes in the previous year. Currently, the country with the most time spent on social media per day is Brazil, with online users spending an average of 3 hours and 49 minutes on social media each day. In comparison, the daily time spent with social media in the U.S. was just 2 hours and 16 minutes. Global social media usageCurrently, the global social network penetration rate is 62.3 percent. Northern Europe had an 81.7 percent social media penetration rate, topping the ranking of global social media usage by region. Eastern and Middle Africa closed the ranking with 10.1 and 9.6 percent usage reach, respectively. People access social media for a variety of reasons. Users like to find funny or entertaining content and enjoy sharing photos and videos with friends, but mainly use social media to stay in touch with current events friends. Global impact of social mediaSocial media has a wide-reaching and significant impact on not only online activities but also offline behavior and life in general. During a global online user survey in February 2019, a significant share of respondents stated that social media had increased their access to information, ease of communication, and freedom of expression. On the flip side, respondents also felt that social media had worsened their personal privacy, increased a polarization in politics and heightened everyday distractions.

Life expectancy is an estimate of how long a person would live, on average.

Life expectancy is affected by many factors such as: • Socioeconomic status, including employment, income, education and economic wellbeing. • The quality of the health system and the ability of people to access it; health behaviors such as tobacco and excessive alcohol consumption, poor nutrition and lack of exercise. • Social factors; genetic factors; and environmental factors including overcrowded housing, lack of clean drinking water and adequate sanitation, etc.

With the help of the above-mentioned factors, I tried to analyse t the data and come up with measurable solutions to improve the Life Expectancy.

Air pollution globalization, as a combined effect of atmospheric transport and international trade, can lead to notable transboundary health impacts. Life expectancy reduction attribution analysis of transboundary pollution can reveal the effect of pollution globalization on the lives of individuals. This study coupled five state-of-the-art models to link the regional per capita life expectancy reduction to cross-boundary pollution transport attributed to consumption in other regions. Our results revealed that pollution due to consumption in other regions contributed to a global population-weighted PM2.5 concentration of 9 μg/m3 in 2017, thereby causing 1.03 million premature deaths and reducing the global average life expectancy by 0.23 year (≈84 days). Trade-induced transboundary pollution relocation led to a significant reduction in life expectancy worldwide (from 5 to 155 days per person), and even in the least polluted regions, such as North America, Western Europe, and Russia, a 12–61-day life expectancy reduction could be attributed to consumption in other regions. Our results reveal the individual risks originating from air pollution globalization. To protect human life, all regions and residents worldwide should jointly act together to reduce atmospheric pollution and its globalization as soon as possible.

Note: DPH is updating and streamlining the COVID-19 cases, deaths, and testing data. As of 6/27/2022, the data will be published in four tables instead of twelve.

The COVID-19 Cases, Deaths, and Tests by Day dataset contains cases and test data by date of sample submission. The death data are by date of death. This dataset is updated daily and contains information back to the beginning of the pandemic. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Cases-Deaths-and-Tests-by-Day/g9vi-2ahj.

The COVID-19 State Metrics dataset contains over 93 columns of data. This dataset is updated daily and currently contains information starting June 21, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-State-Level-Data/qmgw-5kp6 .

The COVID-19 County Metrics dataset contains 25 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-County-Level-Data/ujiq-dy22 .

The COVID-19 Town Metrics dataset contains 16 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Town-Level-Data/icxw-cada . To protect confidentiality, if a town has fewer than 5 cases or positive NAAT tests over the past 7 days, those data will be suppressed.

This dataset includes a count and rate per 100,000 population for COVID-19 cases, a count of COVID-19 molecular diagnostic tests, and a percent positivity rate for tests among people living in community settings for the previous two-week period. Dates are based on date of specimen collection (cases and positivity).

A person is considered a new case only upon their first COVID-19 testing result because a case is defined as an instance or bout of illness. If they are tested again subsequently and are still positive, it still counts toward the test positivity metric but they are not considered another case.

Percent positivity is calculated as the number of positive tests among community residents conducted during the 14 days divided by the total number of positive and negative tests among community residents during the same period. If someone was tested more than once during that 14 day period, then those multiple test results (regardless of whether they were positive or negative) are included in the calculation.

These case and test counts do not include cases or tests among people residing in congregate settings, such as nursing homes, assisted living facilities, or correctional facilities.

These data are updated weekly and reflect the previous two full Sunday-Saturday (MMWR) weeks (https://wwwn.cdc.gov/nndss/document/MMWR_week_overview.pdf).

DPH note about change from 7-day to 14-day metrics: Prior to 10/15/2020, these metrics were calculated using a 7-day average rather than a 14-day average. The 7-day metrics are no longer being updated as of 10/15/2020 but the archived dataset can be accessed here: https://data.ct.gov/Health-and-Human-Services/COVID-19-case-rate-per-100-000-population-and-perc/s22x-83rd

As you know, we are learning more about COVID-19 all the time, including the best ways to measure COVID-19 activity in our communities. CT DPH has decided to shift to 14-day rates because these are more stable, particularly at the town level, as compared to 7-day rates. In addition, since the school indicators were initially published by DPH last summer, CDC has recommended 14-day rates and other states (e.g., Massachusetts) have started to implement 14-day metrics for monitoring COVID transmission as well.

With respect to geography, we also have learned that many people are looking at the town-level data to inform decision making, despite emphasis on the county-level metrics in the published addenda. This is understandable as there has been variation within counties in COVID-19 activity (for example, rates that are higher in one town than in most other towns in the county).

Additional notes: As of 11/5/2020, CT DPH has added antigen testing for SARS-CoV-2 to reported test counts in this dataset. The tests included in this dataset include both molecular and antigen datasets. Molecular tests reported include polymerase chain reaction (PCR) and nucleic acid amplicfication (NAAT) tests.

The population data used to calculate rates is based on the CT DPH population statistics for 2019, which is available online here: https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Population/Population-Statistics. Prior to 5/10/2021, the population estimates from 2018 were used.

Data suppression is applied when the rate is <5 cases per 100,000 or if there are <5 cases within the town. Information on why data suppression rules are applied can be found online here: https://www.cdc.gov/cancer/uscs/technical_notes/stat_methods/suppression.htm

As of 10/22/2020, this dataset is no longer being updated and has been replaced with a new dataset, which can be accessed here: https://data.ct.gov/Health-and-Human-Services/COVID-19-case-rate-per-100-000-population-and-perc/hree-nys2 This dataset includes the average daily COVID-19 case rate per 100,000 population by town over the last two MMWR weeks (https://wwwn.cdc.gov/nndss/document/MMWR_week_overview.pdf). These counts do not include cases among people residing in congregate settings, such as nursing homes, assisted living facilities, or correctional facilities. This dataset will be updated weekly.

This dataset shows daily confirmed and probable cases of COVID-19 in New York City by date of specimen collection. Total cases has been calculated as the sum of daily confirmed and probable cases. Seven-day averages of confirmed, probable, and total cases are also included in the dataset. A person is classified as a confirmed COVID-19 case if they test positive with a nucleic acid amplification test (NAAT, also known as a molecular test; e.g. a PCR test). A probable case is a person who meets the following criteria with no positive molecular test on record: a) test positive with an antigen test, b) have symptoms and an exposure to a confirmed COVID-19 case, or c) died and their cause of death is listed as COVID-19 or similar. As of June 9, 2021, people who meet the definition of a confirmed or probable COVID-19 case >90 days after a previous positive test (date of first positive test) or probable COVID-19 onset date will be counted as a new case. Prior to June 9, 2021, new cases were counted ≥365 days after the first date of specimen collection or clinical diagnosis. Any person with a residence outside of NYC is not included in counts. Data is sourced from electronic laboratory reporting from the New York State Electronic Clinical Laboratory Reporting System to the NYC Health Department. All identifying health information is excluded from the dataset. These data are used to evaluate the overall number of confirmed and probable cases by day (seven day average) to track the trajectory of the pandemic. Cases are classified by the date that the case occurred. NYC COVID-19 data include people who live in NYC. Any person with a residence outside of NYC is not included.

Unemployment Rate in the United States decreased to 4.10 percent in June from 4.20 percent in May of 2025. This dataset provides the latest reported value for - United States Unemployment Rate - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.

RNA half-life estimates from uniformly reprocessed/reanalyzed, published, high quality nucleotide recoding RNA-seq (NR-seq; namely SLAM-seq and TimeLapse-seq) datasets. 12 human cell lines are represented. Data can be browsed at this website.

Analysis notes:

• Data was processed using fastq2EZbakR. All config files used are provided in fastq2EZbakR_config.tar.gz (as well as some for data not included in the final RNAdecayCafe due to QC issues). Some general notes:
  • Multi-mapping reads were filtered out completely. It is difficult to do anything accurate/intelligent with such reads (see discussion here for instance), so better to just get rid of these completely. Does mean that some classes of features rich in repetitive sequences will be underrepresented in this database.
  • Adapters were trimmed. For 3'-end data, 12 additional nucleotides were trimmed from the 5' end of the reads, as suggested by the developers of the popular Quant-seq kit, and as is done by default in SLAMDUNK. Quality score end trimming and polyX trimming is also done for all samples.
• Data was analyzed using EZbakR. Some general notes:
  • If -s4U data was included, this data was used to infer a global pold to stabilize pnew estimation (see Methods here for brief discussion). Dropout was also corrected using a previously devleoped strategy now implemented in EZbakR's CorrectDropout() function.
  • Half-lives are estimated on a gene-level. That is, all reads that map to exonic regions of a gene (i.e., regions that are exonic in at least one annotated isoform) are combined and used to estimate a half-life for that gene. Thus, you should think of these half-life estimates as a weighted average over all isoforms expressed from that gene, weighted by the relative abundances of those isoforms. Future releases may include isoform-resolution estimates as well, given that EZbakR can now perform this type of analysis.
• A unique feature of RNAdecayCafe is that it includes what I am referring to as "dropout normalized" half-life and kdeg estimates. As not all datasets analyzed include -s4U data, dropout correction is not possible for all samples. This can lead to global biases in the average time scale of half-lives that is unlikely to represent real biology (that is, two different K562 datasets may have median half-life estimates of 4 hours and 15 hours). To address this problem and faciltiate comparison across datasets, I developed a strategy (implemented in EZbakR's NormalizeForDropout() function) that uses a model of dropout to normalize estimates with respect to a low dropout sample.
  • These "donorm" estimates will often be a more accurate reflection of rate constants and half-lives in a given cell line.
  • This strategy can normalize out real global differences in turnover kinetics though, so interpret these values with care.

Relevant data provided in this repository are as follows:

1. hg38_Strict.gtf: annotation used for analysis. Filtered similarly to how is described here.
2. AvgKdegs_genes_v1.csv: Table of cell-line average half-lives and degradation rate constants (kdegs). Average log(kdeg)'s are calculated for all samples from a given cell line, weighting by the uncertainty in the log(kdeg) estimate. Columns in this table are as follows:
   1. feature_ID: Gene ID (symbol) from hg38_Strict.gtf
   2. cell_line: Human cell line for which averages are calculated
   3. avg_log_kdeg: Weighted log(kdeg) average
   4. avg_donorm_log_kdeg: Weighted dropout normalized log(kdeg) average.
   5. avg_log_RPKM_total: Average log(RPKM) value from total RNA data. A value of exactly 0 means that there was no total RNA data for this cell line (i.e., all data was 3'-end data).
   6. avg_log_RPKM_3pend: Average log(RPKM) value from 3'-end data. Technically no length normalization is performed as this is 3'-end data, so it is really an log(RPM). A value of exactly 0 means that there was no 3'-end data for this cell line (i.e., all data was for total RNA).
   7. avg_kdeg: e^avg_log_kdeg
   8. avg_donorm_kdeg: e^avg_donorm_log_kdeg
   9. avg_halflife: log(2)/avg_kdeg; can be thought of as average lifetime of the RNA.
   10. avg_donorm_halflife: log(2)/avg_donorm_kdeg
   11. avg_RPKM_total: e^avg_log_RPKM_total
   12. avg_RPKM_3pend: e^avg_log_RPKM_3pend.
3. FeatureDetails_gene_v1.csv: Table of details about each gene measured; information comes from hg38_Strict.gtf and the corresponding hg38 genome FASTA file.
   1. seqnames: chromosome name
   2. strand: strand on which gene is transcribed
   3. start: genomic start position for gene (most 5'-end coordinate; will be location of TES for - strand genes).
   4. end: end position for gene
   5. type: all "gene" for now, as all analyses are currently gene-level average half-life calculations
   6. exon_length: length of union of exons for a given gene. A read is considered exonic, and thus used for half-life estimation, if it exclusively overlaps with the region defined by the union of all annotated exons for that gene.
   7. exon_GC_fraction: fraction of nucleotides in union of exons that are Gs or Cs.
   8. end_GC_fraction: fraction of nucleotides in last 1000 nts of 3'end of transcript that are Gs or Cs. Useful for assessing GC biases in 3'-end data.
   9. feature_ID: Gene ID (symbol) from hg38_Strict.gtf
4. SampleDetails_v1.csv: Table of details about all samples represented in RNAdecayCafe
   1. sample: SRA accession ID for sample
   2. dataset: Citation-esque summary of the dataset of origin
   3. pnew: EZbakR estimated T-to-C mutation rate in reads from new (labeled) RNA. You can see these blogs (here and here) for some intuition as to how to interpret these. More technical explanations of the models involved can be found here and here.
   4. pold: EZbakR estimated T-to-C mutation rate in reads from old (unlabeled) RNA. Same citations for pnew apply. Best samples are those with the largest gap between the pold and pnew; can think of this like a signal-to-noise ratio
   5. label_time: How long (in hours) were cells labeled with s4U for?
   6. cell_line: Cell line used for that sample.
   7. threePseq: TRUE or FALSE; TRUE if 3'-end sequencing was used.
   8. total_reads: Total number of aligned, exonic reads in the sample.
   9. median_halflife: Median, unnormalized half-life estimate. Differences between cell lines could represent real biology, but could also be evidence of dropout (see here and here for discussion of this phenomenon).
5. RateConstants_gene_v1.csv
   1. sample: SRA accession ID for sample.
   2. kdeg: e ^ log_kdeg
   3. halflife: log(2) / kdeg. Can be thought of as the average lifetime of the RNA.
   4. donorm_kdeg: e ^ donorm_log_kdeg
   5. donorm_halflife: log(2) / donorm_kdeg
   6. log_kdeg: log degradation rate constant estimated by EZbakR
   7. donorm_log_kdeg: dropout normalized log degradation rate constant
   8. reads: number of reads that contributed to estimates
   9. donorm_reads: dropout normalization corrected read count
   10. feature_ID: Gene ID (symbol) from hg38_Strict.gtf
6. RNAdecayCafe_database_v1.rds: compressed RDS file that stores a list containing the above 4 tables in the following entries:
   1. kdegs = RateConstants_gene_v1.csv
   2. sample_metadata = SampleDetails_v1.csv
   3. feature_metadata = FeatureDetails_v1.csv
   4. average_kdegs = AvgKdegs_gene_v1.csv
7. RNAdecayCafe_v1_onetable.csv: Inner joining of all but the averages table in this database. Thus, is one mega table containing all sample-specific estimates, sample metadata, and feature information.

Datasets included:

1. Finkel et al. 2021 (Calu3 cells; PMID: 35313595)
2. Harada et al. 2022 (MV411 cells; PMID: 35301220)
3. Ietswaart et al. 2024 (K562 cells; PMID: 38964322); whole-cell data used
4. Luo et al. 2020 (HEK293T cells; PMID: 33357462)
5. Mabin et al. 2025 (HEK293T cells; PMID: 40161772); only dataset for which data is not yet publicly

This is a source dataset for a Let's Get Healthy California indicator at https://letsgethealthy.ca.gov/. Infant Mortality is defined as the number of deaths in infants under one year of age per 1,000 live births. Infant mortality is often used as an indicator to measure the health and well-being of a community, because factors affecting the health of entire populations can also impact the mortality rate of infants. Although California’s infant mortality rate is better than the national average, there are significant disparities, with African American babies dying at more than twice the rate of other groups. Data are from the Birth Cohort Files. The infant mortality indicator computed from the birth cohort file comprises birth certificate information on all births that occur in a calendar year (denominator) plus death certificate information linked to the birth certificate for those infants who were born in that year but subsequently died within 12 months of birth (numerator). Studies of infant mortality that are based on information from death certificates alone have been found to underestimate infant death rates for infants of all race/ethnic groups and especially for certain race/ethnic groups, due to problems such as confusion about event registration requirements, incomplete data, and transfers of newborns from one facility to another for medical care. Note there is a separate data table "Infant Mortality by Race/Ethnicity" which is based on death records only, which is more timely but less accurate than the Birth Cohort File. Single year shown to provide state-level data and county totals for the most recent year. Numerator: Infants deaths (under age 1 year). Denominator: Live births occurring to California state residents. Multiple years aggregated to allow for stratification at the county level. For this indicator, race/ethnicity is based on the birth certificate information, which records the race/ethnicity of the mother. The mother can “decline to state”; this is considered to be a valid response. These responses are not displayed on the indicator visualization.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

The data on relationship to householder were derived from answers to Question 2 in the 2015 American Community Survey (ACS), which was asked of all people in housing units. The question on relationship is essential for classifying the population information on families and other groups. Information about changes in the composition of the American family, from the number of people living alone to the number of children living with only one parent, is essential for planning and carrying out a number of federal programs.

The responses to this question were used to determine the relationships of all persons to the householder, as well as household type (married couple family, nonfamily, etc.). From responses to this question, we were able to determine numbers of related children, own children, unmarried partner households, and multi-generational households. We calculated average household and family size. When relationship was not reported, it was imputed using the age difference between the householder and the person, sex, and marital status.

Household – A household includes all the people who occupy a housing unit. (People not living in households are classified as living in group quarters.) A housing unit is a house, an apartment, a mobile home, a group of rooms, or a single room that is occupied (or if vacant, is intended for occupancy) as separate living quarters. Separate living quarters are those in which the occupants live separately from any other people in the building and which have direct access from the outside of the building or through a common hall. The occupants may be a single family, one person living alone, two or more families living together, or any other group of related or unrelated people who share living arrangements.

Average Household Size – A measure obtained by dividing the number of people in households by the number of households. In cases where people in households are cross-classified by race or Hispanic origin, people in the household are classified by the race or Hispanic origin of the householder rather than the race or Hispanic origin of each individual.

Average household size is rounded to the nearest hundredth.

Comparability – The relationship categories for the most part can be compared to previous ACS years and to similar data collected in the decennial census, CPS, and SIPP. With the change in 2008 from “In-law” to the two categories of “Parent-in-law” and “Son-in-law or daughter-in-law,” caution should be exercised when comparing data on in-laws from previous years. “In-law” encompassed any type of in-law such as sister-in-law. Combining “Parent-in-law” and “son-in-law or daughter-in-law” does not represent all “in-laws” in 2008.

The same can be said of comparing the three categories of “biological” “step,” and “adopted” child in 2008 to “Child” in previous years. Before 2008, respondents may have considered anyone under 18 as “child” and chosen that category. The ACS includes “foster child” as a category. However, the 2010 Census did not contain this category, and “foster children” were included in the “Other nonrelative” category. Therefore, comparison of “foster child” cannot be made to the 2010 Census. Beginning in 2013, the “spouse” category includes same-sex spouses.

This dataset contains counts of deaths for California as a whole based on information entered on death certificates. Final counts are derived from static data and include out-of-state deaths to California residents, whereas provisional counts are derived from incomplete and dynamic data. Provisional counts are based on the records available when the data was retrieved and may not represent all deaths that occurred during the time period. Deaths involving injuries from external or environmental forces, such as accidents, homicide and suicide, often require additional investigation that tends to delay certification of the cause and manner of death. This can result in significant under-reporting of these deaths in provisional data.

The final data tables include both deaths that occurred in California regardless of the place of residence (by occurrence) and deaths to California residents (by residence), whereas the provisional data table only includes deaths that occurred in California regardless of the place of residence (by occurrence). The data are reported as totals, as well as stratified by age, gender, race-ethnicity, and death place type. Deaths due to all causes (ALL) and selected underlying cause of death categories are provided. See temporal coverage for more information on which combinations are available for which years.

The cause of death categories are based solely on the underlying cause of death as coded by the International Classification of Diseases. The underlying cause of death is defined by the World Health Organization (WHO) as "the disease or injury which initiated the train of events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury." It is a single value assigned to each death based on the details as entered on the death certificate. When more than one cause is listed, the order in which they are listed can affect which cause is coded as the underlying cause. This means that similar events could be coded with different underlying causes of death depending on variations in how they were entered. Consequently, while underlying cause of death provides a convenient comparison between cause of death categories, it may not capture the full impact of each cause of death as it does not always take into account all conditions contributing to the death.

Overview The Human Vital Signs Dataset is a comprehensive collection of key physiological parameters recorded from patients. This dataset is designed to support research in medical diagnostics, patient monitoring, and predictive analytics. It includes both original attributes and derived features to provide a holistic view of patient health.

Attributes Patient ID

Description: A unique identifier assigned to each patient. Type: Integer Example: 1, 2, 3, ... Heart Rate

Description: The number of heartbeats per minute. Type: Integer Range: 60-100 bpm (for this dataset) Example: 72, 85, 90 Respiratory Rate

Description: The number of breaths taken per minute. Type: Integer Range: 12-20 breaths per minute (for this dataset) Example: 16, 18, 15 Timestamp

Description: The exact time at which the vital signs were recorded. Type: Datetime Format: YYYY-MM-DD HH:MM Example: 2023-07-19 10:15:30 Body Temperature

Description: The body temperature measured in degrees Celsius. Type: Float Range: 36.0-37.5°C (for this dataset) Example: 36.7, 37.0, 36.5 Oxygen Saturation

Description: The percentage of oxygen-bound hemoglobin in the blood. Type: Float Range: 95-100% (for this dataset) Example: 98.5, 97.2, 99.1 Systolic Blood Pressure

Description: The pressure in the arteries when the heart beats (systolic pressure). Type: Integer Range: 110-140 mmHg (for this dataset) Example: 120, 130, 115 Diastolic Blood Pressure

Description: The pressure in the arteries when the heart rests between beats (diastolic pressure). Type: Integer Range: 70-90 mmHg (for this dataset) Example: 80, 75, 85 Age

Description: The age of the patient. Type: Integer Range: 18-90 years (for this dataset) Example: 25, 45, 60 Gender

Description: The gender of the patient. Type: Categorical Categories: Male, Female Example: Male, Female Weight (kg)

Description: The weight of the patient in kilograms. Type: Float Range: 50-100 kg (for this dataset) Example: 70.5, 80.3, 65.2 Height (m)

Description: The height of the patient in meters. Type: Float Range: 1.5-2.0 m (for this dataset) Example: 1.75, 1.68, 1.82 Derived Features Derived_HRV (Heart Rate Variability)

Description: A measure of the variation in time between heartbeats. Type: Float Formula: 𝐻 𝑅

𝑉

Standard Deviation of Heart Rate over a Period Mean Heart Rate over the Same Period HRV= Mean Heart Rate over the Same Period Standard Deviation of Heart Rate over a Period ​

Example: 0.10, 0.12, 0.08 Derived_Pulse_Pressure (Pulse Pressure)

Description: The difference between systolic and diastolic blood pressure. Type: Integer Formula: 𝑃

𝑃

Systolic Blood Pressure − Diastolic Blood Pressure PP=Systolic Blood Pressure−Diastolic Blood Pressure Example: 40, 45, 30 Derived_BMI (Body Mass Index)

Description: A measure of body fat based on weight and height. Type: Float Formula: 𝐵 𝑀

𝐼

Weight (kg) ( Height (m) ) 2 BMI= (Height (m)) 2

Weight (kg) ​

Example: 22.8, 25.4, 20.3 Derived_MAP (Mean Arterial Pressure)

Description: An average blood pressure in an individual during a single cardiac cycle. Type: Float Formula: 𝑀 𝐴

𝑃

Diastolic Blood Pressure + 1 3 ( Systolic Blood Pressure − Diastolic Blood Pressure ) MAP=Diastolic Blood Pressure+ 3 1 ​ (Systolic Blood Pressure−Diastolic Blood Pressure) Example: 93.3, 100.0, 88.7 Target Feature Risk Category Description: Classification of patients into "High Risk" or "Low Risk" based on their vital signs. Type: Categorical Categories: High Risk, Low Risk Criteria: High Risk: Any of the following conditions Heart Rate: > 90 bpm or < 60 bpm Respiratory Rate: > 20 breaths per minute or < 12 breaths per minute Body Temperature: > 37.5°C or < 36.0°C Oxygen Saturation: < 95% Systolic Blood Pressure: > 140 mmHg or < 110 mmHg Diastolic Blood Pressure: > 90 mmHg or < 70 mmHg BMI: > 30 or < 18.5 Low Risk: None of the above conditions Example: High Risk, Low Risk This dataset, with a total of 200,000 samples, provides a robust foundation for various machine learning and statistical analysis tasks aimed at understanding and predicting patient health outcomes based on vital signs. The inclusion of both original attributes and derived features enhances the richness and utility of the dataset.